CAPITAL IMPACT ADVISORS, LLC – Madrigal Pharmaceuticals, Inc. Transaction History
CAPITAL IMPACT ADVISORS, LLC portfolio value:
$570,000
portfolio value
CAPITAL IMPACT ADVISORS, LLC quarter portfolio value change:
-9.21%
quarter
Madrigal Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -14K | $64.99 | 8.16K | |
| Q2 2022 | share | Decrease | -35.00% | -4.39K shares | -648K | $71.58 | 8.16K |
| Q1 2022 | share | Decrease | -31.20% | -5.69K shares | -314K | $98.12 | 12.55K |
| Q4 2021 | share | Increase | +54.98% | 6.47K shares | 606K | $84.89 | 18.24K |
| Q3 2021 | share | 0.00% | 0 shares | -207K | $79.79 | 11.77K | |
| Q2 2021 | share | Decrease | -64.37% | -21.27K shares | -2.71M | $97.41 | 11.77K |
| Q1 2021 | share | Increase | +35.72% | 8.69K shares | 1.15M | $116.97 | 33.04K |
| Q4 2020 | share | Increase | 0.00% | 24.35K shares | 2.70M | $111.17 | 24.35K |
| Q3 2020 | share | Decrease | -100.00% | -24.35K shares | -2.75M | $118.73 | 0 |
| Q2 2020 | share | 0.00% | 0 shares | 1.13M | $113.25 | 24.35K | |
| Q1 2020 | share | Increase | +4.26% | 996 shares | -502K | $66.76 | 24.35K |
| Q4 2019 | share | Increase | +13.41% | 2.76K shares | 375K | $91.11 | 23.35K |
| Q3 2019 | share | Increase | +13.47% | 2.44K shares | -70K | $86.22 | 20.59K |
| Q2 2019 | share | Increase | +32.86% | 4.48K shares | 396K | $104.81 | 18.14K |
| Q1 2019 | share | 0.00% | 0 shares | 0 | $125.26 | 13.65K | |
| Q4 2018 | share | Increase | +89.68% | 6.45K shares | -102K | $112.72 | 13.65K |
| Q3 2018 | share | Increase | +9.02% | 596 shares | -307K | $214.13 | 7.20K |
| Q2 2018 | share | Decrease | -41.00% | -4.59K shares | 529K | $279.69 | 6.60K |
| Q1 2018 | share | Increase | 0.00% | 11.19K shares | 1.30M | $116.79 | 11.19K |